Unbound MEDLINE

Transforming Growth Factorbeta-1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells. Journal of cellular and molecular medicine [J Cell Mol Med] Journal article

 
TitleTransforming Growth Factorbeta-1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells.
Author(s)Churchman AT, Anwar AA, Li FY, Sato H, Ishii T, Mann GE, Siow RC 
InstitutionCardiovascular Division, School of Medicine, King's College London, UK.
SourceJ Cell Mol Med 2008 Dec 24.
AbstractThe anti-inflammatory properties of transforming growth factorbeta-1 (TGFbeta-1) account for its protection against atherosclerotic plaque rupture. This study investigates whether activation of the Nrf2 transcription pathway is involved in TGFbeta-1 mediated induction of the antioxidant enzyme heme oxygenase-1 (HO-1) in smooth muscle cells (SMC). Human (HAoSMC) or wild-type and Nrf2 deficient mouse (MAoSMC) aortic SMC were treated with TGFbeta-1 (2.5-10 ng/ml, 0-24 h). We report the first evidence that TGFbeta-1 induces Nrf2 mediated HO-1 expression and antioxidant response element activity, which was paralleled by enhanced superoxide production and expression of the NAD(P)H oxidase subunit p22(phox). TGFbeta-1 failed to induce HO-1 expression in MAoSMC derived from Nrf2 deficient mice, and HO-1 induction by TGFbeta-1 in HAoSMC was attenuated by inhibition of extracellular signal regulated kinase or c-jun-N-terminal kinase but not p38 mitogen activated protein kinase. Inhibition of NAD(P)H oxidase or scavenging of superoxide diminished HO-1 induction in response to TGFbeta-1. The oxidative stress agents glucose oxidase and diethylmaleate enhanced TGFbeta-1 generation and HO-1 expression in HAoSMC, while antagonism of TGF(-1 signalling by adenoviral Smad7 overexpression attenuated their induction of HO-1. Pretreatment of HAoSMC with TGF(-1 reduced nuclear translocation of the pro-apoptotic mediator p53 elicited by glucose oxidase. Our findings demonstrate that Nrf2 is a new target of TGFbeta-1 signalling in the vasculature which may contribute to the atheroprotective properties attributed to this growth factor.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19413896
  
Advertise on this site.